Prostate cancer mortality in areas with high and low prostate cancer incidence.
Stattin, Pär (författare)
Umeå universitet,Urologi och andrologi,Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY
Carlsson, Sigrid (författare)
Gothenburg University,Göteborgs universitet,Lund University,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY USA; Univ Gothenburg, Dept Urol, Sahlgrenska Acad, Gothenburg, Sweden
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Dept Urol, Sahlgrenska Acad, Gothenburg, Sweden
The effect of prostate-specific antigen (PSA) screening on prostate cancer mortality remains debated, despite evidence from randomized trials. We investigated the association between prostate cancer incidence, reflecting uptake of PSA testing, and prostate cancer mortality.
Ämnesord
MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Nephrology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)